| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/08/2014 | US8772348 Materials and methods for pest control |
| 07/08/2014 | US8772347 Use of a pharmaceutical composition for promoting proliferation and/or migration of skin cells, and for improving wound healing in a subject |
| 07/08/2014 | US8772346 Pharmaceutical composition |
| 07/08/2014 | US8772345 Oximes for treatment of peripheral and central nervous system exposure to acetyl cholinesterase inhibitors |
| 07/08/2014 | US8772344 Pharmaceutical composition for inhibiting osteoclast growth |
| 07/08/2014 | US8772343 Chemical compounds |
| 07/08/2014 | US8772342 Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders |
| 07/08/2014 | US8772341 Compositions for the treatment of hoof diseases |
| 07/08/2014 | US8772340 Process for the preparation of fesoterodine or a salt thereof |
| 07/08/2014 | US8772339 Ethylgallate and related compounds as a treatment for sepsis and septic shock |
| 07/08/2014 | US8772338 Enhanced bimatoprost ophthalmic solution |
| 07/08/2014 | US8772337 Preservative-free prostaglandin-based ophthalmic solution |
| 07/08/2014 | US8772336 Cathepsin cysteine protease inhibitors |
| 07/08/2014 | US8772335 Adamantyl derivatives as therapeutic agents |
| 07/08/2014 | US8772333 Fumigillol type compounds and methods of making and using same |
| 07/08/2014 | US8772332 Arylpropionyl-alpha-pyrone antibacterial agents |
| 07/08/2014 | US8772331 Small molecule antagonists of bacterial quorum-sensing receptors |
| 07/08/2014 | US8772330 Inhibitor(s) of transporters or uptake of monoaminergic neurotransmitters |
| 07/08/2014 | US8772329 Compounds from mycelium of Antrodia cinnamomea and use thereof |
| 07/08/2014 | US8772328 Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes |
| 07/08/2014 | US8772327 Phenylpropionic acid derivative and use thereof |
| 07/08/2014 | US8772326 Methods and compositions of small molecule modulators of hepatocyte growth factor (scatter factor) activity |
| 07/08/2014 | US8772325 Compounds as opioid receptor modulators |
| 07/08/2014 | US8772324 Composition and methods for the treatment of wounds |
| 07/08/2014 | US8772323 Benzoxazole- and tetrahydrobenzoxazole-substituted pyridazinones as GPR119 agonists |
| 07/08/2014 | US8772322 Synergistic preservative compositions |
| 07/08/2014 | US8772321 Heteroannelated anthraquinone derivatives for inhibiting cancers |
| 07/08/2014 | US8772319 Diagnostic and therapeutic alkyl piperidine/piperazine compounds and process |
| 07/08/2014 | US8772318 Methods and compositions related to targeting monoacylglycerol lipase |
| 07/08/2014 | US8772317 Aqueous pharmaceutical suspensions containing rebamipide and manufacturing process thereof |
| 07/08/2014 | US8772316 Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (PDE10A) |
| 07/08/2014 | US8772315 Pharmaceutical composition for treating overactive bladder |
| 07/08/2014 | US8772314 Glycine derivatives and medicinal compositions thereof |
| 07/08/2014 | US8772313 Benzenesulfonyl or sulfonamide compounds suitable for treating disorders that respond to the modulation of the serotonin 5-HT6 receptor |
| 07/08/2014 | US8772312 Heterocyclic compounds as CRTH2 receptor antagonists |
| 07/08/2014 | US8772311 Harmine derivatives, intermediates used in their preparations, preparation processes and use thereof |
| 07/08/2014 | US8772309 Pharmaceutical formulation of apomorphine for buccal administration |
| 07/08/2014 | US8772308 Non-peptidyl, potent, and selective mu opioid receptor antagonists |
| 07/08/2014 | US8772307 Substituted spiro compounds and their use for producing pain-relief medicaments |
| 07/08/2014 | US8772306 Method of administration of gamma hydroxybutyrate with monocarboxylate transporters |
| 07/08/2014 | US8772305 Substituted pyridinyl-pyrimidines and their use as medicaments |
| 07/08/2014 | US8772304 Benzimidazole inhibitors of leukotriene production |
| 07/08/2014 | US8772303 Pharmaceutical formulation |
| 07/08/2014 | US8772302 GPR 119 agonists |
| 07/08/2014 | US8772301 Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof |
| 07/08/2014 | US8772299 Phenyl piperazine compounds, pharmaceutical composition including the same and use thereof |
| 07/08/2014 | US8772298 Spirocyclic heterocycles medicaments containing said compounds, use thereof and method for their production |
| 07/08/2014 | US8772297 TGF-β signal transduction inhibitor |
| 07/08/2014 | US8772296 Benzamide derivatives and uses related thereto |
| 07/08/2014 | US8772295 Modulators of aldehyde dehydrogenase and methods of use thereof |
| 07/08/2014 | US8772294 Crystalline forms for 5-amino-2, 3-dihydrophthalazine-1, 4-dione sodium salt, pharmaceutical preparations containing the same and method for the production of said forms |
| 07/08/2014 | US8772293 Chemical compounds |
| 07/08/2014 | US8772292 Process for the preparation of a medicament comprising vardenafil hydrochloride trihydrate |
| 07/08/2014 | US8772291 Multicyclic compounds and methods of their use |
| 07/08/2014 | US8772290 Alpha-arylmethoxyacrylate derivative, preparation method thereof, and pharmaceutical composition containing same |
| 07/08/2014 | US8772288 Substituted spiro[cycloalkyl-1,3′-indo]-2′(1′H)-one derivatives and their use as P38 mitogen-activated kinase inhibitors |
| 07/08/2014 | US8772287 Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy |
| 07/08/2014 | US8772286 MK2 inhibitors |
| 07/08/2014 | US8772285 Benzothiazoles having histamine H3 receptor activity |
| 07/08/2014 | US8772284 Method of treating cancer using combination of a bifunctional alkylating agent and DNA repair inhibitors |
| 07/08/2014 | US8772283 Imidazo-oxazine compound or salt thereof |
| 07/08/2014 | US8772282 Tetrahydropyrrolothiazine compounds |
| 07/08/2014 | US8772281 Remedy for diabetes |
| 07/08/2014 | US8772280 N-aryl-2-(2-arylaminopyrimidin-4-yl)pyrrol-4-carboxamide derivatives as MPS1 kinase inhibitors |
| 07/08/2014 | US8772279 6,7-dihydroimidazo[1,5-a]pyrazin-8(5H)-one derivatives as protein kinase modulators |
| 07/08/2014 | US8772278 Angiotensin II receptor antagonist for the prevention or treatment of systemic diseases in cats |
| 07/08/2014 | US8772277 Nitrogen-containing heterocyclic compound |
| 07/08/2014 | US8772276 Alkyne benzotriazole derivatives |
| 07/08/2014 | US8772275 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 07/08/2014 | US8772274 Anti-cancer compositions and methods |
| 07/08/2014 | US8772273 Formulations and uses of retinoic acid receptor selective agonists |
| 07/08/2014 | US8772272 Pyrido-and pyrimidopyrimidine derivatives as anti-proliferative agents |
| 07/08/2014 | US8772271 Micronized tanaproget, compositions, and methods of preparing the same |
| 07/08/2014 | US8772270 Treatment methods requiring phyto-ingredients |
| 07/08/2014 | US8772269 Use of sulfonamide-including compounds in combination with angiogenesis inhibitors |
| 07/08/2014 | US8772267 Treatment of spinal mechanical pain |
| 07/08/2014 | US8772265 Water soluble curcumin compositions for use in anti-cancer and anti-inflammatory therapy |
| 07/08/2014 | US8772264 Methods of treating hematologic cancers |
| 07/08/2014 | US8772263 Methods and compositions for protecting or treating muscarinic receptors through administration of pyrophosphate analog in subjects exposed to toxic or carcinogenic metals or metal ions |
| 07/08/2014 | US8772260 Methods for inhibiting expression of connective tissue growth factor |
| 07/08/2014 | US8772253 Aureolic acid derivatives, the method for preparation thereof and the uses |
| 07/08/2014 | US8772252 Coumarin compounds as melanogenesis modifiers and uses thereof |
| 07/08/2014 | US8772251 Use of isothiocyanate derivatives as anti-myeloma agents |
| 07/08/2014 | US8772250 Compositions and methods for treating ischemia and ischemia-reperfusion injury |
| 07/08/2014 | US8772249 Compositions and methods for treating ischemia and ischemia-reperfusion injury |
| 07/08/2014 | US8772246 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 07/08/2014 | US8772242 Therapy for enteric infections |
| 07/08/2014 | US8772230 Niacin and/or trigonelline as a muscle stimulant |
| 07/08/2014 | US8772225 Biomarkers for multiple sclerosis |
| 07/08/2014 | US8772013 Methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells |
| 07/08/2014 | US8771973 Methods for treating bleeding disorders using sulfated polysaccharides |
| 07/08/2014 | US8771764 Composition and method for improving vascular health |
| 07/08/2014 | US8771760 Method for the treatment of constipation |
| 07/08/2014 | US8771750 Delivery or removal of metals from biological systems |
| 07/08/2014 | US8771740 Process for producing nanoparticles by spray drying |
| 07/08/2014 | US8771739 Pharmaceutical compositions for poorly soluble drugs |
| 07/08/2014 | US8771733 Pharmaceutical composition containing an anti-nucleating agent |
| 07/08/2014 | US8771732 Sustained release formulations of nalbuphine |
| 07/08/2014 | US8771731 Antimicrobial nanoemulsion compositions and methods |
| 07/08/2014 | US8771729 Orally administered corticosteroid compositions |